David L Saunders
Uniformed Services University of the Health Sciences
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name David L Saunders as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 03:40 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT05481177 · Ivabradine for Long-Term Effects of COVID-19 With POTS CohortUniformed Services University of the Health Sciences · unknown · Long Haul COVID, Postural Orthostatic Tachycardia Syndrome · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 03:40 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 03:40 UTC. The ranking covers the 200 most relevant of 6 PubMed records, and a shared surname and initials can bring in a namesake. All 6 on PubMed
- Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.N Engl J Med · 2019209 citationsRCR 11.6
- Dihydroartemisinin-piperaquine failure in Cambodia.N Engl J Med · 2014193 citationsRCR 7.0
- 30 citationsRCR 1.4
- Assessment of the relative potency of fentanyl buccal tablet to intravenous morphine in healthy volunteers using a thermally induced hyperalgesia pain model.J Clin Pharmacol · 20129 citationsRCR 0.4
- 7 citationsRCR 0.3
- Evaluating malaria elimination strategies among military forces in Cambodia: a multi-arm clinical trial comparing monthly prophylaxis and focused screening and treatment.BMC Infect Dis · 20253 citationsRCR 1.3